Liou, L.-B.; Tsai, P.-H.; Fang, Y.-F.; Chen, Y.-F.; Chang, C.-T.; Chen, C.-C.; Chiang, W.-Y.
B-Cell ST6Gal1/Neuraminidase 1 Ratios Inversely Predict the Combined Remission and Low-Disease-Activity Subgroup with DAS28-MCP-1 and SDAI Scores for Rheumatoid Arthritis. Int. J. Mol. Sci. 2025, 26, 8226.
https://doi.org/10.3390/ijms26178226
AMA Style
Liou L-B, Tsai P-H, Fang Y-F, Chen Y-F, Chang C-T, Chen C-C, Chiang W-Y.
B-Cell ST6Gal1/Neuraminidase 1 Ratios Inversely Predict the Combined Remission and Low-Disease-Activity Subgroup with DAS28-MCP-1 and SDAI Scores for Rheumatoid Arthritis. International Journal of Molecular Sciences. 2025; 26(17):8226.
https://doi.org/10.3390/ijms26178226
Chicago/Turabian Style
Liou, Lieh-Bang, Ping-Han Tsai, Yao-Fan Fang, Yen-Fu Chen, Che-Tzu Chang, Chih-Chieh Chen, and Wen-Yu Chiang.
2025. "B-Cell ST6Gal1/Neuraminidase 1 Ratios Inversely Predict the Combined Remission and Low-Disease-Activity Subgroup with DAS28-MCP-1 and SDAI Scores for Rheumatoid Arthritis" International Journal of Molecular Sciences 26, no. 17: 8226.
https://doi.org/10.3390/ijms26178226
APA Style
Liou, L.-B., Tsai, P.-H., Fang, Y.-F., Chen, Y.-F., Chang, C.-T., Chen, C.-C., & Chiang, W.-Y.
(2025). B-Cell ST6Gal1/Neuraminidase 1 Ratios Inversely Predict the Combined Remission and Low-Disease-Activity Subgroup with DAS28-MCP-1 and SDAI Scores for Rheumatoid Arthritis. International Journal of Molecular Sciences, 26(17), 8226.
https://doi.org/10.3390/ijms26178226
